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The unfolded protein response (UPR) is a hallmark of
numerous liver diseases including cancer. Here, we report
that in the liver, netrin-1 protects against UPR-related cell
death through UPR-resistant, internal ribosome entry site–
driven translation, and the UNC5/death-associated protein
kinase pathway.
BACKGROUND & AIMS: Netrin-1, a multifunctional secreted
protein, is up-regulated in cancer and inﬂammation. Netrin-1
blocks apoptosis induced by the prototypical dependence
receptors deleted in colorectal carcinoma and uncoordinated
phenotype-5. Although the unfolded protein response (UPR)
triggers apoptosis on exposure to stress, it ﬁrst attempts to
restore endoplasmic reticulum homeostasis to foster cell sur-
vival. Importantly, UPR is implicated in chronic liver conditions
including hepatic oncogenesis. Netrin-1’s implication in cell
survival on UPR in this context is unknown.
METHODS: Isolation of translational complexes, determination
of RNA secondary structures by selective 2’-hydroxyl acylation
and primer extension/dimethyl sulfate, bicistronic constructs,
as well as conventional cell biology and biochemistry
approaches were used on in vitro–grown hepatocytic cells,
wild-type, and netrin-1 transgenic mice.
RESULTS: HepaRG cells constitute a bona ﬁde model for UPR
studies in vitro through adequate activation of the 3 sensors of
the UPR (protein kinase RNA–like endoplasmic reticulum kinase
(PERK)), inositol requiring enzyme 1a (IRE1a), and activated
transcription factor 6 (ATF6). The netrin-1 messenger RNA 5’-
end was shown to fold into a complex double pseudoknot and
bear E-loop motifs, both of which are representative hallmarks of
related internal ribosome entry site regions. Cap-independent
translation of netrin 5’ untranslated region–driven luciferase
was observed on UPR in vitro. Unlike several structurally related
oncogenic transcripts (l-myc, c-myc, c-myb), netrin-1 messenger
RNA was selected for translation during UPR both in human
hepatocytes and in mice livers. Depletion of netrin-1 during UPR
induces apoptosis, leading to cell death through an uncoordinated
phenotype-5A/C–mediated involvement of protein phosphatase
2A and death-associated protein kinase 1 in vitro and in netrin
transgenic mice.CONCLUSIONS: UPR-resistant, internal ribosome entry
site–driven netrin-1 translation leads to the inhibition of
uncoordinated phenotype-5/death-associated protein kinase
1–mediated apoptosis in the hepatic context during UPR, a
hallmark of chronic liver disease. (Cell Mol Gastroenterol Hepatol
2016;2:281–301; http://dx.doi.org/10.1016/j.jcmgh.2015.12.011)
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he endoplasmic reticulum (ER) is the place of
1Tsecretory and membrane protein synthesis. Folding
of newly synthesized proteins within the ER lumen is tightly
monitored by dedicated quality control machinery.2
Perturbation of ER homeostasis caused by hypoxia, viral
infection, or other stressors can reduce or surpass the ER
folding capacity, resulting in a condition termed ER stress.3
Chronic ER stress is observed in several diseases including
cancer.4–6 Likewise, ER stress plays a well-documented role
in hepatitis B virus (HBV)- and hepatitis C virus (HCV)-
related pathogenesis,7–9 implicating it as a factor in liver
disease and carcinogenesis.7,10–12 To restore homeostasis in
response to ER stress, cells activate the unfolded protein
response (UPR), a process involving the sequential
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like endoplasmic reticulum kinase (PERK), activated tran-
scription factor 6 (ATF6), and inositol requiring enzyme 1a
(IRE1a).13 PERK phosphorylates the elongation factor
Eukaryotic translation initiation factor 2A (eIF2a) at Ser-51,
impeding protein translation. If the UPR fails to restore ER
homeostasis, it instead reverts to apoptosis.13 One of the
mediators of UPR-induced apoptosis is the death-associated
protein kinase 1 (DAPK1), a key regulator of cell death.14
DAPK1 is activated by protein phosphatase 2A (PP2A) in a
process that requires interactors including calmodulin, and,
interestingly, the Unc-5 homolog B (UNC5B),15,16 suggesting
a potential involvement of extracellular or autocrine factors.
UNC5B is one of 4 members of the UNC5-family (UNC5A,
UNC5B, UNC5C, and UNC5D), belonging to the so-called
dependence receptors (DRs),17 promoting cell survival as long
as they are engaged by their ligands. Once unbound, these re-
ceptors trigger apoptosis.17–19 Netrin-1 is the canonical soluble
partner of DRs. It initially was identiﬁed as an axonal guidance
molecule of thedeveloping central nervous system.20 In thepast
decade, several studies have reported that netrin-1 is up-
regulated in several types of cancer19,21–24 and cancer-
associated inﬂammatory diseases conferring cells with a
selective advantage regarding survival and proliferation.25–27
Netrin-1 is upregulated in cancers in general and in cancer-
associated associated inﬂammatory diseases. Intriguingly,
netrin-1 is increased by 10- to 30-fold upon HBV or HCV
infection in an epidermal growth factor receptor–dependent
manner in the latter case, and also in cirrhosis irrespective of its
etiology (Plissonnier et al, unpublished data). From what is
known, UNC5A andC induce apoptosis through the recruitment
of neurotrophin receptor-interacting MAGE homolog or the
activationof theE2FTranscriptionFactor 1 transcription factor,
respectively.15,16 As mentioned earlier, UNC5B binds and sig-
nals via DAPK1, triggering a signal cascade that has been well
described. Brieﬂy, in the presence of netrin-1, the UNC5B re-
ceptor interacts with an inactive, phosphorylated form of
DAPK1. In the absence of netrin-1, UNC5B adopts an open
conformation and recruits Serine/threonine-protein phospha-
tase 2A 65 kDa regulatory subunit A beta isoform (PR65b)/
PP2A into an UNC5B/DAPK1 complex followed by caspase-3
activation.16 Two recent studies have suggested a link
between netrin-1 and the UPR.28,29 Given the already known
association of UNC5B and DAPK1 with this process, we sought
to investigate the role of netrin-1/UNC5-controlled apoptosis in
UPR-associated cell death.
In the liver, common triggers include viral infections,
alcoholic liver disease, or genetic conditions, all of which are
high risk factors for hepatocellular carcinoma.7–9,30–32 The
UPR is a hallmark of these pathophysiological contexts.
Here, we show that during experimentally induced UPR,
netrin-1 is efﬁciently translated through an internal ribo-
some entry site (IRES) both in vitro and in vivo in mice
livers. Modulation of netrin-1 in hepatocytic cells conditions
caspase-3 activation and affects cell death via UNC5A- and
UNC5C-mediated increase of PP2A activity and implication
of DAPK1. Our results indicate that netrin-1 protects hepa-
tocytes against UPR-related cell death through resistance to
UPR-related global translational inhibition.Materials and Methods
Cell Culture
HepaRG cells were cultured as previously described.33
The human hepatoma cell line Huh7.5 was grown in
Dulbecco’s modiﬁed Eagle medium (Life Technologies,
Carlsbad, CA), supplemented with 10% fetal bovine serum
(Thermo Scientiﬁc, Waltham, MA), 1 penicillin-
streptomycin (Life Technologies), and 1 glutamax (Life
Technologies). Cells were maintained in a 5 % CO2 atmo-
sphere at 37C and harvested at day 3 after plating.
Neutralizing netrin-1 antibody 2F5 and the isotypic control
H4 were obtained from Netris Pharma (Lyon, France). ER
stress was induced by treating cells with tunicamycin (Tu)
(Sigma-Aldrich, St. Louis, MO) or dithiothreitol (DTT)
(Sigma-Aldrich) as indicated before harvest.Mice Models
All trials were performed under Institutional Review
Board agreement CECCAP_CLB_2014_015. Six-week-old
C57BL6 mice (Charles River Laboratory, Saint-Germain-
Nuelles, France) were treated intraperitoneally with 1 mg/
kg Tu or phosphate-buffered saline (PBS) for 24 hours
and killed. Rosa-Lox-Stop-Lox (LSL)-netrin-1 transgenic
mice conditionally overexpress ﬂag-tagged netrin-1 under
the control of a Rosa26 promoter. These animals were
crossed with Rosa-CreERT2 (tamoxifen-dependent Cre
recombinase) þ/þ mice to generate breeder pairs of con-
trol and conditional overexpressers. Each mouse carries one
copy of the CreERT2 transgene and was genotyped for
LSL–netrin-1. At the age of 8 weeks, mice were injected
intraperitoneally with 100 mL of 10 mg/mL tamoxifen
(diluted in corn oil/ethanol, 9/1) daily, for 3 consecutive
days to induce netrin-1 overexpression. After 2 weeks, mice
were genotyped and netrin-1–overexpressing mice and
their breeder pairs of control were treated with Tu or PBS
for UPR induction for 24 hours and then killed.Quantitative and Conventional
Reverse-Transcription Polymerase
Chain Reaction
For quantitative reverse-transcription polymerase chain
reaction (qRT-PCR), total RNA was extracted from cultured
cells using the Extract-all reagent (Eurobio, Courtaboeuf,
France) or the Nucleospin RNA/protein kit (Macherey-
Nagel, Duren, Germany) for liver samples. RNA (1 mg) was
treated with DNase I (Promega, Madison, WI), and then
reverse transcribed in the presence of 5% dimethyl sulf-
oxide, using the Moloney Murine Leukemia Virus Reverse
Transcriptase enzyme, according to the manufacturer’s in-
structions (Invitrogen). Real-time qRT-PCR was performed
on a LightCycler 480 device (Roche, Basel, Switzerland)
using the iQTM SYBR 533 Green Supermix (Bio-Rad, Her-
cules, CA). Dimethyl sulfoxide (10%; Sigma-Aldrich) was
added to the PCR reaction for human netrin-1 quantiﬁca-
tion. Conventional RT-PCR was performed to amplify
unspliced and spliced forms of XBP1 messenger RNA
(mRNA), using the GoTaq DNA Polymerase according to the
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loaded on a 4% agarose gel to allow the separation between
the 2 isoforms. PCR primer sequences and conditions are
listed in Supplementary Tables 1 and 2.
Isolation of Polysomal RNAs
Isolation of polysomal RNAs was performed as described
previously.34 RNA was extracted using acid phenol and RNA
integrity was monitored by gel electrophoresis on a 1.2%
agarose gel. Densitometry (GelDoc; Bio-Rad) was used to
determine fractions in which the 28S/18S ratio equaled 1.6
(ie, fractions corresponding to polysome-bound RNA). Spe-
ciﬁc mRNA distribution in the sucrose gradient was deter-
mined by qRT-PCR as described in the previous section with
an equal volume of RNA from each fraction.
Bicistronic Approach: Cloning Strategy
Bicistronic constructs were generated based on the
Bicistronic plasmid (pBic) vector described by Giraud
et al.35 Sequences corresponding to the HCV IRES (nucleo-
tides 1–376) or the netrin-1 5’ untranslated region (UTR)
(nucleotides 1–107) were synthesized by Genscript (Hong
Kong, China) and then subcloned into the pBic vector be-
tween the Renilla and Fireﬂy Luciferase coding regions after
digestion with EcoRI and NarI. The cytomegalovirus (CMV)
promoter was deleted from the pBic netrin-1 5’UTR after
digestion by HindIII and BglII to obtain the pBic netrin-1
5’UTR DCMV promoter.
DNA Templates and RNA Synthesis
To monitor dimethyl sulfate (DMS) and N-methyl-isatoic
anhydride (NMIA) reactivity of the netrin-1 5’UTR, a
45-nucleotide cassette was attached to its 3’ terminus, as
previously described.36 This cassette has been reported to
fold autonomously into 2 short, stable hairpins37 that do not
interfere with the predicted folding of the 5’UTR of netrin-1.
It also contains a primer binding site for efﬁcient comple-
mentary DNA synthesis. Brieﬂy, the DNA template
(T7p-5’UTR_ netrin-1) was obtained from the plasmid pGL-
netrin-1 5’UTR 1–294 by ampliﬁcation using the oligonu-
cleotides T7p5’UTR_ netrin-1 and cas-as5’UTR_ netrin-1
(Supplementary Table 3). The RNA encoding the HCV
IRES, 5’HCV-698, was obtained after in vitro transcription of
BamH1 digested pU5’HCV-691 plasmid.38 RNA100 was
obtained by in vitro transcription from the plasmid pBSSK
(Promega) previously digested with XbaI. Internal radio-
labeling of RNA transcripts used for the 40S binding assays
was essentially performed as reported.39 RNA synthesis was
performed using the TranscriptAid T7 High Yield Tran-
scription Kit following the manufacturer’s instructions
(Thermo Scientiﬁc). The resulting transcripts were puriﬁed
as previously described.40
40S Ribosomal Subunit Puriﬁcation
Ribosomal particles (40S) were isolated from Huh-7
cell S10 extracts essentially as described.41 Brieﬂy, Huh-7
cells were grown to 90% conﬂuence in 10% calfserum–supplemented Dulbecco’s modiﬁed Eagle medium,
washed twice with cold PBS, treated with trypsin, and
collected by centrifugation. Pellets were washed twice with
10 volumes of isotonic buffer (35mmol/L Hepes-KOH pH 7.6,
146 mmol/L NaCl, and 11 mmol/L glucose) and diluted
further into 1.5 volumes of hypotonic solution (20 mmol/L
Hepes-KOH, pH 7.6, 10 mmol/L KCl, 1.5 mmol/L magnesium
acetate, 1mmol/LDTT, and protease inhibitors). The solution
was incubated for 20 minutes at 4C, supplemented with 0.2
volume of S10 buffer (100 mmol/L Hepes-KOH, pH 7.6, 600
mmol/L AcK, 20 mmol/L magnesium acetate, 25 mmol/L
DTT, and protease inhibitors), and then broken with 20
strokes of a glass dounce homogenizer. A postnuclei super-
natant was obtained by centrifugation at 5000g for 10 mi-
nutes. Polysomes were precipitated from this lysate by
ultracentrifugation at 40,000 rpm (70.1 Ti rotor; Beckman,
Brea, CA) for 4 hours in a 0.25 mol/L sucrose solution con-
taining 20 mmol/L Tris-HCl, pH 7.6, 2 mmol/L DTT, 6 mmol/
L MgCl2, and 0.5 mol/L KCl (buffer A). Pellets were diluted in
buffer B (20 mmol/L Tris-HCl, pH 7.6, 2 mmol/L DTT, 6
mmol/L MgCl2, and 150 mmol/L KCl) to a concentration of
50–150 A260 U/mL. This suspension was incubated with 4
mmol/L puromycin for 10 minutes at 4C and for 30 minutes
at 37C before the addition of KCl to a ﬁnal concentration of
0.5 mol/L. Ribosomal subunits were resolved by centrifuga-
tion of 0.3-mL aliquots of this suspension through a 10%–
30% sucrose gradient in buffer A for 17 hours at 4C and
28,000 rpm, using a Beckman SW40 rotor. Subunits (40S)
were concentrated from 0.5-mL gradient fractions with
Amicon Ultracel-10k (Millipore Billerica, MA).
Assembly of Netrin-1 5’UTR–40S Complexes and
Filter Binding Assays
To generate RNA–40S subunit complexes, 32P end-labeled
5’UTR netrin-1 RNA constructs were ﬁrst denatured by
heating at 95C for 2 minutes and then cooled to 4C. Binding
reactions were initiated by mixing 1 nmol/L of the RNA
transcript in folding/binding buffer (30 mmol/L Hepes-
NaOH, pH 7.4, 100 mmol/L sodium acetate, 5 mmol/L mag-
nesium acetate, and 2 mmol/L DTT) with increasing
concentrations of the 40S ribosomal subunit. Reactions were
incubated at 37C for 30 minutes before loading on 0.45-mm
nitrocellulose ﬁlters (GE Healthcare, Little Chalfont, UK). The
ﬁlters were presoaked in the binding buffer, assembled in a
dot blot apparatus, and the samples thenwere added directly
onto the ﬁlter under vacuum. The ﬁlters then were removed,
dried, and scanned in a Phosphorimager (Storm 820; GE
Healthcare) and quantiﬁed with Image Quant 5.2 software
(GE Healthcare). Values are the average of at least 3 inde-
pendent experiments. For the competition reactions, 40S-
5’UTR assembly was performed as described earlier in the
presence of a molar excess of the unlabeled transcripts
RNA100, 5’UTR netrin-1, or 5’HCV-698 HCV IRES.
DMS Probing
DMS chemical probing was performed essentially as pre-
viously described.40 Fluorescently labeled DNA oligonucleo-
tides (Applied Biosystems, Carlsbad, CA) used for primer
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denaturing polyacrylamide gels. Primer Std (Supplementary
Table 3), which anneals within the structure cassette inser-
ted at the 3’ end of the respective transcript, was labeled
ﬂuorescently with NED (to detect untreated and treated
probes) or VIC (for sequencing reaction). For the primer
extension reaction, 0.4 pmol of gel-puriﬁed primer were
hybridized with the total processed RNA by incubation at
95C for 2 minutes, followed by fast cooling at 4C for 5
minutes and subsequent incubation at 52C, to allow efﬁcient
annealing. Extension reactions were performed for 30
minutes at 52C in a 20-mL reaction containing reverse-
transcriptase buffer, 0.5 mmol/L deoxynucleoside triphos-
phate, and 100 U SuperScript III RT (Invitrogen). RNA
sequencing reactions were performed under identical condi-
tions with the VIC ﬂuorescently labeled primer in the pres-
ence of 0.25 mmol/L of ddCTP 20,30-Dideoxycytidine
50-Triphosphate. The resulting complementary DNA samples
were puriﬁed and resolved as reported40,42 in the genomic
unit of the IPBLN-CSIC. Electropherograms were analyzed
using QuSHAPE software.43 Normalized DMS reactivity values
for each nucleotide position were obtained by dividing each
value by the average intensity of the 10% most reactive res-
idues, after excluding outliers calculated by box plot analysis.
Selective 2’-Hydroxyl Acylation and Primer
Extension Analysis
Selective 2’-hydroxyl acylation and primer extension
analyses were performed by treatment with NMIA as pre-
viously described.40 Normalized NMIA reactivity values for
each nucleotide position were calculated as indicated for
DMS probing.
Secondary Structure Prediction
RNA secondary structure models were generated using
ShapeKnots software (University of Rochester, Rochester,
NY),44 including the structural constraints derived from
NMIA and DMS relative reactivity data.
Small Interfering RNA–Mediated Knockdown
A total of 2  104 cells/cm2 were transfected with 25
nmol/L ﬁnal concentration of a nontargeting control small
interfering RNA (siRNA), netrin-1 siRNA, UNC5A siRNA,
UNC5C siRNA, DAPK1 siRNA, or PR65b siRNA (designed by
Sigma-Aldrich) using Lipofectamine 2000 (Invitrogen) ac-
cording to the manufacturer’s instructions. Sequences of
siRNAs are listed in Supplementary Table 4.
Plasmid Transfection
A total of 3  105 cells were transfected with 2.5 mg
netrin-1 or neuronal vanilloid receptor 1 (VR1) expression
plasmids or bicistronic constructs using Lipofectamine 2000
(Invitrogen), according to the manufacturer’s instructions.
Caspase-3 and Proliferation Assays
Caspase-3 activity assays were performed using the
caspase 3/CPP32 Colorimetric Assay Kit, according to themanufacturer’s instructions (Gentaur Biovision, Kampenh-
out, Belgium). The cell proliferation assay was performed
using neutral red uptake standard assay.45PP2A Activity Assays
PP2A activity was measured using the active PP2A
DuoSet IC kit according to the manufacturer’s instructions
(R&D Systems, Minneapolis, MN).Fluorescence-Activated Cell Sorter Analyses
HepaRG cells were detached with Versene buffer (Life
Technologies), washed twice in PBS, and centrifuged at
1200 rpm for 5 minutes. Cells then were stained in a mix
containing 1 mg/mL RNase-A (Invitrogen) and 100 mg/mL
propidium iodide (Sigma-Aldrich) for 5 minutes at room
temperature, washed in PBS, resuspended in PBS supple-
mented with 10 mmol/L EDTA, and analyzed using a
FACscalibur device (BD, Franklin Lakes, NJ).Immunoblotting
Immunoblotting was performed using standard pro-
tocols with antibodies against the human inﬂuenza hemag-
glutinin (HA) tag (Sigma-Aldrich), FLAG-M2 (Sigma-Aldrich),
b-actin (Sigma-Aldrich), total DAPK1 (Sigma-Aldrich),
PR65b (Abcam, Cambridge, UK), netrin-1 antibody (AF1109;
R&D Systems), eIF2a (Cell Signaling), Phospho-eIF2a (9721,
Ser-51 speciﬁc; Cell Signaling), and a-tubulin (Thermo Sci-
entiﬁc). Antibody information is available in Supplementary
Table 5.Terminal Deoxynucleotidyl Transferase–Mediated
Deoxyuridine Triphosphate Nick-End Labeling
Staining and Netrin-1 Immunochemistry
Terminal deoxynucleotidyl transferase–mediated deox-
yuridine triphosphate nick-end labeling (TUNEL) staining
and netrin-1 immunochemistry were performed by the
Anipath core facility (Inserm, Lyon, France), using the R&D
systems TUNEL kit and an antibody directed against netrin-
1 (MAB1109; R&D Systems) (Supplementary Table 5).Northern Blot
Cells transfected with the previously mentioned con-
structs were lysed in TRIzol (Life Technologies). A total of
10 mg of total RNA extracts were denatured in glyoxal and
underwent agarose gel electrophoresis, transferred onto a
nylon membrane by capillary blotting, blocked, and hy-
bridized using the Church and Gilbert procedure with 20
pmol of Fluc reverse primer (Supplementary Table 3) pre-
viously labeled with 32P.Statistical Analysis
Statistical analysis was conducted using the
Mann–Whitney or Wilcoxon tests with GraphPad Prism (La
Jolla, CA) software 5.0. Signiﬁcance was as follows: *P < .05,
**P < .01, ***P < .001.
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The UPR Is Functional in HepaRG Cells
To analyze the role of netrin-1 in the UPR in the liver, we
ﬁrst veriﬁed the presence of a functional UPR in HepaRG
cells. HepaRG cells are a recognized, untransformed, human
liver cell line that closely resembles primary human hepa-
tocytes.46,47 We treated cells with different doses of DTT or
Tu and monitored translational status by evaluation of the
phosphorylation level of eIF2a at Ser-51, a mark associated
with a rapid decrease in protein biosynthesis.48 We also
monitored the transcriptional induction of a number ofA
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Figure 1. The UPR is induced upon DTT treatment in Hepa
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. (A) Immunoblotting showing eIF2a phosphorylation levels.
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regulated by 4- to 6-fold, respectively (Figure 1B and 1C).
Splicing of XBP1 mRNA was detected as early as 30 minutes
after treatment with DTT, increased in a time- and
dose-dependent manner, and reached its maximum at 4
hours after treatment with 2.5 mmol/L DTT (Figure 1D).
p58IPK mRNA levels also were induced by approximately
3-fold at 4–8 hours after treatment (Figure 1E). GRP94 and
CHOP mRNA levels also increased up to 10- and 100-fold at
4–8 hours after treatment (Figure 1F and 1G). UPR-related
transcripts also were induced, yet substantially later and
weaker after having treated HepaRG cells with Tu
(Figure 2). Altogether, these results indicate that the UPR isTu (μg/mL) Tu (μg/mL) Tu (μg/mL) Tu (μg/mL)
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in vitro experiments and XBP1 mRNA splicing served as an
indicator for a functional UPR.49Netrin-1 Translation Is Resistant to UPR-Related
Translational Shutdown in Human Cells
Next we assessed if the UPR affected netrin-1 expression
in the samples from Figure 1. Interestingly, total netrin-1
mRNA levels were insensitive to the UPR (Supplementary
Figure 1). Because the UPR has a strong effect on trans-
lation, we further investigated the effect of the UPR on2α (Ser51)
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May 2016 Netrin–1 and the UPR in the Liver 287netrin-1 translation by quantifying the association of
netrin-1 mRNA with polysomes through sucrose gradient
fractionation. Polysome association of b-actin and GUS
mRNAs served as control. In addition, IRES-bearing mRNAs
encoding the oncogenes l-myc,50 c-myb,51 and c-myc52 were
included. The latter were chosen based on the results from a
basic local alignment tool search performed using the IRE-
Site database, which suggested that the 5’UTRs of netrin-1, l-
myc (e-value: 0.001) and c-myb (e-value: 0.016 and 0.61,
depending on the region studied) are located between nu-
cleotides 5 to 63 and 75 to 106, respectively (Figure 3A).53
c-myc was included as a control of an oncogenic transcript
with an unrelated 5’UTR structure. To this end, HepaRG
cells were treated with 2.5 mmol/L DTT for 4 hours, a
setting in which UPR was activated efﬁciently. As expected,
polyribosomal dissociation was observed in response to
DTT (Figure 3B). The position of the earlier-mentioned
mRNAs across the sucrose gradient were measured by
qRT-PCR. The limit between nonpolysomal and polysomal
fractions was set based on the 28S/18S intensity ratio. In
this setting, b-actin mRNA association with polysomes
decreased from 91% to 44% after DTT treatment (corre-
sponding to a reduction of 50%), whereas netrin-1 mRNA
association with polysomes remained unchanged (92%)
(Figure 3B). Similar results ranging from 15% to more
than 40% changes were observed for gus, l-myc, c-myb,
and c-myc (Supplementary Figure 2). In contrast, poly-
some association of the IRES-bearing ATF4 transcript
variant 1 mRNA (ATF4 V1)54 (not indexed in the IRESite
database), which is known to be induced during UPR, was
increased by approximately 30%. Interestingly, polysome
association of l-myc, c-myb, or c-myc transcripts decreased
with their decreasing similarity with the netrin-1 5’UTR
(Figure 3C). Similar results were obtained in Huh7.5 cells,
a human hepatocytic cell line (Supplementary Figures 3
and 4). Altogether, our data suggest that netrin-1 mRNA
remains associated with translational units during the
UPR, suggesting its involvement in UPR-associated pro-
cesses mediating cell survival.Netrin-1 mRNA Is Translated Through IRES-
Dependent Translation
One possible explanation for the earlier-described ﬁndings
would be the existence of an IRES element in the 5’UTR of the
netrin-1mRNA. To test this hypothesis, bicistronic constructs
containing the 5’UTR of netrin-1 or the HCV IRES between the
Renilla luciferase (rluc) and the Fireﬂy luciferase (ﬂuc) gene
were generated.35 In these constructs, RLuc translation is
initiated by a cap-dependent manner and FLuc synthesis de-
pends on the potential ribosome recruitment mediated by the
inserted netrin-1 5’UTR sequence. The Fluc/Rluc activity ratio
increased in a dose-dependent manner after DTT treatment
(Figure 4A). Indeed, cap-dependent translation measured as
RLuc activity was decreased substantially, whereas FLuc
synthesis, which is driven by the 5’UTR of netrin-1, was not
affected (Figure 4B and C). This is in good concordance with
the observation that the HCV IRES also was able to efﬁciently
drive FLuc translation during the UPRbut at a lower level thanthe netrin-1 5’UTR (Figure 4A). No luciferase activity was
detected using vectors lacking the CMV promoter (Figure 4B
and C). Moreover, a uniquemRNA population was detected by
Northern blot and FLuc/RLuc mRNA ratios were not modiﬁed
after DTT treatment, indicating that the netrin-1 5’UTR
sequence is devoid of promoter activity and of cryptic splice
site (Figure 4D and E). The observation that the 5’UTR of the
netrin-1 mRNA can promote the translation of an internal
cistron is consistent with the presence of an IRES. To further
corroborate this hypothesis, we assessed recruitment of the
40S ribosome by the netrin-1 5’UTR. As shown in Figure 4F,
the netrin-1 5’UTR recruits the 40S particle with a low nano-
molar afﬁnity range (Kd ¼ 28.21 ± 2.03 nmol/L). No compe-
tition was observed using a nonrelated molecule, RNA 100,
verifying the speciﬁcity of the interaction. Interestingly, an
RNA transcript containing theHCV IRES38 efﬁciently displaced
the interaction between the netrin-1 5’UTR and the 40S sub-
units to a similar extent as the nonlabeled netrin-1 5’UTR
(Figure 4G). This suggests that the 5’UTR of netrin-1 mRNA
recruits the 40S ribosomal subunit in the absence of any other
translation factor and with similar efﬁciency to the HCV IRES.
Taken together, our results support the presence of an IRES in
the 5’UTR of the netrin-1mRNA.Structural Mapping of the 5’UTR Netrin-1 mRNA
There is an intimate relationship between the function of
an RNA molecule and its architecture. This prompted us to
analyze the folding of the 5’-end of the netrin-1 mRNA,
comprising the putative IRES and the ﬁrst few nucleotides of
the coding sequence. To this end, RNA was analyzed by DMS
chemical probing assays and selective 2’-hydroxyl acylation
and primer extension analyses with a NMIA reagent.
Both DMS and NMIA reactivity proﬁles showed a low
global mean reactivity value (Figure 5A and B), with local
and well-delimited average reactivity peaks, suggesting a
compact folding with long stem structures closed by apical
loops. The experimental data then were used to further
deﬁne secondary structure models using the ShapeKnots
tool provided by the RNAStructure software package
(Mathews lab software, Rochester, NY).44 As shown in
Figure 5C, our analysis yielded a well-deﬁned architecture
with 2 major stem loops (regions 2 and 3), ﬂanked by
2 short hairpins (1 and 4). Furthermore, it provided an
interesting view of the 3’ end of the 5’UTR, suggesting this
speciﬁc region showed a relatively relaxed folding with
2 possible conformations (folding 1 and 2). Both architec-
tures can be considered thermodynamically equivalent
structural isoforms, likely being transitions from one to
another. In the ﬁrst conformation, stem 3 is organized
around a 3-way junction, which may serve as a protein
recruiting platform.55 In the second version, the RNA
adopts a structure resembling a single long stem inter-
rupted by internal loops and bulges, mainly deﬁned by
noncanonical RNA G-A base pairs, which frequently are
found in these so-called E-loops. Interestingly, a common
and unique double pseudoknot element formed by the very
5’-end of the 5’UTR of the sequence was preserved in both
conformations.
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May 2016 Netrin–1 and the UPR in the Liver 289Although complete experimental evidence for these
structures remains to be generated, these structural data
reﬂect the probable existence of 2 prominent structural iso-
forms, which could be related to a translational switch mech-
anism, from cap-dependent to IRES-dependent translation.
Netrin-1 Confers Protection Against
UPR-Induced Cell Death
To determine whether translated netrin-1 indeed medi-
ates cell survival during the UPR, we assessed the effect of
netrin-1 depletion on several cell death parameters. First,
HepaRG cells were transfected with control or netrin-
1–targeting siRNAs and then treated with DTT over time.
The netrin-1 protein level was reduced signiﬁcantly, indi-
cating a successful knockdown (Figure 6A). The XBP1mRNA
proﬁle showed an induction of the UPR (Figure 6B).
Depletion of netrin-1 led to an increase in the percentage of
dead cells (DTT vs mock) from 20% to 60% (Figure 6C), and
a 6-fold enhancement of caspase-3 activity 4 hours after
treatment (Figure 6D). In addition, apoptotic cells in the
sub-G1 phase were determined by propidium iodide stain-
ing and ﬂow cytometry. The number of apoptotic cells in
netrin-1–depleted samples was increased up to 4-fold at 4
hours after treatment (Figure 6E). Comparable results were
obtained using a netrin-1–neutralizing antibody instead of
siRNA, conﬁrming the protective role of netrin-1 and
excluding off-target effects (Figure 6F–H).
To determine whether netrin-1 overexpression had the
opposite effect, HepaRG cells were transfected with plas-
mids encoding either netrin-1–HA or VR1-HA as control and
treated with DTT for up to 24 hours. Immunoblotting
conﬁrmed expression of netrin-1–HA and VR1-HA proteins
in the transfected cells (Figure 6I). UPR induction was
conﬁrmed by consideration of XBP1 splicing (Figure 6J). In
contrast to netrin-1 knockdown, overexpression decreased
cell death and caspase-3 activity by 2.5- to 3-fold (Figure 6K
and L). Likewise, apoptotic cells were decreased by 20%
(Figure 6M). Altogether, these results suggest that netrin-1
confers protection against UPR-induced cell death in hepa-
tocytes in vitro.
UNC5A/C Signaling Through DAPK1/PR65b
Induces Caspase-3 Activation During UPR
Netrin-1 is the ligand of the UNC5 DRs.17 To identify the
receptor(s) responsible for caspase-3 activation in the
absence of netrin-1, we ﬁrst veriﬁed the expression of each
netrin-1–receptor mRNA in HepaRG cells. As shown in
Figure 7A, only UNC5A and UNC5C are expressed toFigure 3. (See previous page). Netrin-1 mRNA association wi
were treated with DTT for 4 hours. Cell lysates were subjected
cation of GUS, b-actin, netrin-1, l-myc, c-myb, c-myc, and ATF
0.001) and c-myb (e-values, 0.016 and 0.61). Bioinformatic ana
tribution of mRNAs after sucrose gradient fractionation. Bar
Agarose gel electrophoreses represent ribosomal RNA distribu
indicated mRNAs with polysomes upon DTT treatment was
associated signals in DDT vs mock samples in each proﬁle (m
tRNA, transfer RNA.detectable levels. Consequently, HepaRG cells were ﬁrst
transfected with each receptor’s siRNAs and then treated
with DTT. Importantly, transfection of the individual siRNAs
had no effect on XBP1 mRNA splicing and thus induction of
the UPR (Figure 7B). Knockdown of netrin-1 protein was
validated by immunoblotting (Figure 7C). Because of the
lack of validated commercialized or in-house–generated
antibodies, UNC5A and UNC5C silencing was veriﬁed by
qRT-PCR. Their mRNA levels were decreased by at least 2-
fold. No cross-reactivity between UNC5 siRNAs could be
observed (Figure 7D and E). In line with our previous re-
sults, caspase-3 activity increased up to 25-fold in cells
transfected with netrin-1 siRNA. Interestingly, double
knockdown of netrin-1 and UNC5A or UNC5C rescued
netrin-1 depletion-induced caspase-3 activation. Although
UNC5A depletion led to a reduction of 60%, UNC5C
completely reverted caspase-3 activation (Figure 7F). Alto-
gether these results indicate that caspase-3 activation trig-
gered by the UPR is mediated by UNC5A/C pro-apoptotic
pathways in the absence of netrin-1.
DAPK1 recently was identiﬁed as a mediator of apoptosis
in response to ER stress.14 The UNC5B pro-apoptotic
pathway also activates DAPK1,16 suggesting a potential link
between DAPK1 and UNC5A and UNC5C-conveyed signals
during UPR. As before, HepaRG cells were transfected with
control siRNA alone or with a combination of 2 siRNAs
directed against netrin-1, DAPK1, or PR65b. UPRwas veriﬁed
by XBP1 mRNA splicing (Figure 7G). Knockdown efﬁcacies
were assessed by immunoblotting for netrin-1, DAPK1, and
PR65b (Figure 7H). As expected, netrin-1 depletion increased
caspase-3 activity. Interestingly, this was partially and fully
rescued by PR65b and DAPK1 knockdown, respectively
(Figure 7I). To further corroborate the involvement of the
DAPK1 pathway, we decided to also quantify the activity of
PP2A, a DAPK1 phosphatase involved in the induction of
apoptosis.16 The PP2A activity ratio was increased by 2-fold
in cells transfected with netrin-1 siRNA. This activity
returned to baseline upon depletion of PR65b, a PP2A regu-
latory subunit (Figure 7J). In summary, our results suggest
that in hepatocytes, UPR-induced apoptosis is mediated by
UNC5A and UNC5C receptors and involves the DAPK1/PP2A
complex.16Netrin-1 Translation Is Resistant to UPR-Related
Translational Shutdown in Mice Livers
To test if our in vitro results could be veriﬁed in vivo, we
treated C57BL6 wild-type mice with PBS or Tu for 24 hours
using a published protocol.56 As previously shown, theth translational units is resistant to the UPR. HepaRG cells
to polysome fractionation followed by qRT-PCR for quantiﬁ-
4 V1 mRNAs. (A) netrin-1 5’UTR is similar to l-myc (e-value,
lysis was performed using IRESite (http://iresite.org). (B) Dis-
graphs represent b-actin and netrin-1 mRNA quantiﬁcation.
tion across gradient. (C) The evolution of the association of
determined as the percentage difference of the polysome-
ean þ SEM, n ¼ 3). See also Supplementary Figures 2–4.
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Figure 4. (See previous page). Netrin-1 mRNA is translated through IRES-dependent translation. HepaRG cells were
transfected with bicistronic vectors carrying the netrin-1 5’UTR or the HCV IRES between the Rluc and Fluc coding regions.
Three days after transfection, cells were treated for 4 hours with increasing amounts of DTT or left untreated. (A) The netrin-1
5’UTR allows Fluc translation in a bicistronic construct upon UPR. (B) Renilla luciferase activity (RLU) is decreased after DTT
treatment. (C) Fireﬂy luciferase activity (RLU) is differentially modulated after DTT treatment. (D) Northern blot showing the
presence of a unique mRNA population of the expected size being synthesized. Equal loading was conﬁrmed by 18S and 28S
intensities. (E) FLuc/RLuc mRNA ratio is unchanged after DTT treatment. (F) The interaction between the netrin-1 5’UTR and
the 40S ribosomal subunit is concentration-dependent. Internally 32P-labeled netrin-1 5’UTR transcript was incubated with
puriﬁed 40S particles in binding buffer. Complexes were detected by ﬁlter retention (mean ± SD, n ¼ 3). (G) The interaction
between the netrin-1 5’UTR and 40S subunit is displaced by the HCV IRES. The internally 32P-labeled netrin-1 5’UTR RNA was
incubated with the puriﬁed 40S particle in the presence of increasing amounts of the unlabeled transcripts (mean ± SD, n ¼ 3).
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292 Lahlali et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 3livers of Tu-treated mice turned pale, indicating UPR-
induced inhibition of liver function (Figure 8A).56 Immu-
nohistochemistry showed that netrin-1 expression wasinsensitive to Tu (Figure 8B). Shutdown of protein trans-
lation was veriﬁed by considering the phosphorylation level
of eIF2a at Ser-51 in Tu-treated mice (Figure 8C). GADD34,
May 2016 Netrin–1 and the UPR in the Liver 293GRP94, total XBP1, CHOP, and p58IPK mRNA levels were
induced by 10-, 5-, 10-, 100-, and 20-fold, respectively, in
treated vs control mice (Figure 8D–H). Induction of spliced
XBP1 mRNA in Tu-treated mice also was observed
(Figure 8I). Taken together, these data suggest that the UPR
is appropriately activated in these mice.
Next, we performed polysome proﬁling of livers from
treated or control mice to monitor netrin-1 translation in
context of the UPR. Netrin-1 proﬁles were compared with the
same controls previously used in human cells, the only
exception being l-myc mRNA, which was not detectable in
mouse livers. Distribution of ribosomal RNAs after sucrose
gradient fractionation indicated destabilization of polysomes
by Tu as shown by agarose gel electrophoresis (Figure 9A,
upper panel). Accordingly, b-actin mRNA association with
polysomes was decreased from 88% to 77% after treatment,
whereas netrin-1 mRNA association with polysomes
increased from 22% to 29% (Figure 9A, lower panels). This
corresponded to a decrease in polysome association of 12%
for b-actin mRNA, 10% for GUS mRNA, and to an increase of
27% for netrin-1 and 21% for ATF4 V1mRNA (Figure 9B). As
shown in vitro, polysome association of the control proto-
oncogenes c-myb or c-myc transcripts decreased with their
decreasing similarity with the netrin-1 5’UTR (Figure 9B and
Supplementary Figure 5). In accordance with our in vitro
results, netrin-1 translation even was affected positively by
UPR-related translational shutdown in mice.
Netrin-1 Inhibits UPR-Related Caspase-3
Activation in Mice Liver
To conclude this study, we wanted to determine whether
netrin-1–overexpressing transgenic mice could provide
further evidence for the protective role of netrin-1 during
the UPR.
Rosa-LSL-netrin-1 transgenic mice were crossed with
Rosa-CreERT2þ/þ mice to generate breeder pairs of controlFigure 6. (See previous page). Netrin-1 protects against cell
cells were transfected with netrin-1 siRNA, treated with DTT,
knockdown by siRNA was validated by immunoblot (representat
(representative result, n ¼ 3). (C) UPR increases the dependen
difference in cell death (in percentages) (mean þ SEM; n ¼ 3; Ma
cells toward netrin-1 for caspase-3 activation. Graphs indicate c
test; P < .05). (E) Netrin-1 depletion increases apoptosis. Gra
staining and ﬂow cytometry (mean þ SEM; n ¼ 3; Mann–Whitn
antibody. HepaRG cells were seeded and treated with a control
treated with DTT 3 days after addition and harvested after the i
(representative result, n ¼ 3). (G) Netrin-1 neutralization enhanc
ratios between 2F5 and H4-treated cells (mean þ SEM; n ¼ 3; M
apoptosis. Graph indicates the apoptotic cell death ratio as as
netrin-1–depleted and control cells (mean þ SEM; n ¼ 3; Ma
HepaRG cells were transfected with control (VR1-HA) and netrin
Netrin-1 expression was assessed by immunoblotting. Represen
RT-PCR at the indicated time points. Representative result, n ¼
protection against cell death in time course assays. Graph ind
netrin-1–overexpressing cells and control cells (mean þ SEM;
sensitivity of cells toward netrin-1 for caspase-3 activation in
activation levels among netrin-1–overexpressing and control c
Netrin-1 overexpression decreases apoptosis in a time cours
assessed after propidium iodide staining and ﬂow cytometry of n
Mann–Whitney test; P < .05). *,**, or *** refer to statistical analyand conditional overexpressers of FLAG-tagged netrin-1.
Animals were treated with tamoxifen to induce netrin-1
overexpression and then genotyped by RT-qPCR. Netrin-1
mRNA was increased by 40- and 60-fold in transgenic
mice compared with their wild-type counterparts when
injected with PBS and Tu, respectively (Supplementary
Figure 6A). Furthermore, anti-FLAG immunoblotting and
immunohistochemistry conﬁrmed netrin-1 overexpression
(Figure 10A and B). As was the case in wild-type mice, liver
of Tu-treated mice turned pale (Figure 10C). Again, Tu-
treated mice showed induction of eIF2a phosphorylation at
Ser-51 compared with their PBS-treated controls, indicating
an attenuation of protein translation (Figure 10D). Activation
of the PERK, ATF6, and IRE1a pathways by Tu were
conﬁrmed by induction of GADD34 (3-fold), total XBP1 (2-
fold), GRP94 (10-fold), CHOP (50-fold), and p58IPK (15-fold)
mRNA levels and XBP1 mRNA splicing (Supplementary
Figure 6B–G). We then analyzed the impact of netrin-1 on
caspase-3 activity upon Tu treatment. As shown in
Figure 10E, caspase-3 activity increased by 1.5-fold in control
mice, but returned to baseline in netrin-1–overexpressing
mice. In addition, TUNEL staining was performed by immu-
nohistochemistry to quantify the increase of apoptotic cells.
Although the number of TUNEL-positive cells was low in
accordance with its end-stage apoptosis marker status, it was
increased by 6-fold in control mice (Figure 10F). In contrast,
TUNEL-positive cell numbers remained insensitive to Tu
treatment in netrin-1 transgenic mice.
Altogether, these results suggest that netrin-1 protects
against UPR-induced liver cell death in vivo.
Discussion
After ER stress, cells activate a UPR to restore ER ho-
meostasis, culminating in the PERK-mediated attenuation of
protein synthesis. In this context, translation can occur
through 2 distinct mechanisms. For example, the 5’UTRdeath during UPR. (A–H) Netrin-1 depletion. (A–E) HepaRG
and harvested in a time course assay. (A) Netrin-1 protein
ive result, n ¼ 3). (B) XBP1 splicing was conﬁrmed by RT-PCR
ce of cells toward netrin-1 for survival. Graphs indicate the
nn–Whitney test; P < .05). (D) UPR increases the sensitivity of
aspase-3 activity ratios (mean þ SEM; n ¼ 3; Mann–Whitney
ph indicates apoptotic cell death ratio by propidium iodide
ey test; P < .05). (F–H) Netrin-1 inhibition using a neutralizing
(H4) or anti–netrin-1 antibody (2F5) the same day. Cells were
ndicated time points. (F) Assessment of XBP1 mRNA splicing
es caspase-3 activity. Graph indicates the caspase-3 activity
ann–Whitney test; P < .05). (H) Netrin-1 depletion increases
sessed after propidium iodide staining and ﬂow cytometry of
nn–Whitney test; P < .05). (I–M) Netrin-1 forced expression.
-1 (netrin-1–HA) vectors, treated with DTT, and harvested. (I)
tative result, n ¼ 3. (J) XBP1 mRNA splicing was quantiﬁed by
3. (K) UPR increases the sensitivity of cells toward netrin-1 for
icates the difference in cell death (in percentages) between
n ¼ 3; Mann–Whitney test; P < .05). (L) UPR increases the
time course assays. Graph indicates the ratios of caspase-3
ells (mean þ SEM; n ¼ 3; Mann–Whitney test; P < .05). (M)
e assay. Graph indicates the apoptotic cell death ratio as
etrin-1–overexpressing and control cells (mean þ SEM; n ¼ 3;
ses.
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allows its translation in a Cap-dependent manner. This is
owing to a decreased translation of its 2 upstream Open
Reading Frames, which are negative translation regulatorelements.57 Intron retention in ATF4 5’UTR allows ATF4 V1
mRNA transcription and translation in an IRES-dependent
manner.54 Bioinformatic analysis showed a striking simi-
larity between nucleotides 5 and 63 of netrin-1 5’UTR and
May 2016 Netrin–1 and the UPR in the Liver 295the 5’UTR of l-myc, and between nucleotides 75 and 106
with the 5’UTR of c-myb mRNAs, both of which carry an
IRES.50,51 Polysome association of these transcripts
increased along with their increasing similarity with the
netrin-1 5’UTR. Moreover, ATF4 V1 mRNA is associated
strongly with polysomes during the UPR.54 These observa-
tions lead us to hypothesize that during UPR: (1) carrying an
IRES is not enough for an mRNA to be translated efﬁciently,
(2) a particular IRES folding seems to be required, and (3)
netrin-1 mRNA is translated in a cap-independent manner
(netrin-1 5’UTR contains no uORF). This last point is
supported further by the high guanine-cytosine content in
the 5’UTR (>80%) of the transcript. In addition, the netrin-1
5’UTR was able to drive translation of an internal
reporter cistron in a UPR intensity-dependent manner and
efﬁciently recruited the 40S ribosomal subunit. Here, we
show that in addition to the increased translation of several
UPR-related targets such as ATF4 V154 and CAT1 mRNA,58
netrin-1 translation is conserved or even stimulated in an
IRES-dependent manner upon UPR-related translational
shutdown.
RNA function is dependent on its architecture. Netrin-1
5’UTR structural analyses predicted a double pseudoknot
formed by long-range interactions of the very 5’-end of the
5’UTR and the ﬁrst nucleotides of the coding sequence. This
element is a rare structural RNA motif previously described
in viral and some cellular IRESs.59 In fact, it acts as the core
nucleation center in the HCV IRES, mediating proper folding
of each domain and the successful ﬁtting of the resulting
structure into the 40S ribosomal subunit.60 In addition,
several so-called E-loops present throughout the entire
netrin-1 mRNA 5’-end were predicted. These are functional
elements that promote the formation of accurately shaped
scaffolds mediating protein recruitment and RNA–RNA in-
teractions. Taken together, our functional and structural
data provide strong support for the existence of an IRES
element in the netrin-1 5’UTR. The translational induction of
netrin-1 during hypoxia, during which cap-dependent
translation is attenuated, further corroborates our results.61
In this study, we also show that netrin-1 plays a pro-
tective role in experimentally induced UPR, both in vitro and
in vivo. UNC5A or UNC5C knockdown reduces caspase-3,
suggesting that these dependence receptors mediate
apoptosis during the UPR. There are no existing data onFigure 7. (See previous page). UNC5A and UNC5C induce ca
Quantiﬁcation of netrin-1–receptor expression by qRT-PCR (mea
receptors. HepaRG cells were transfected with siRNAs and treat
mRNA splicing by RT-PCR. Representative result, n ¼ 3. (C) As
Representative result, n ¼ 3. (D and E) Assessment of transcrip
UNC5C mRNA levels in siRNA-treated cells in comparison
Mann–Whitney test; P < .05). (F) Caspase-3 activation is reve
Graph indicates caspase-3 activity ratio of DTT vs untreated cell
P < .05). (G–J) Identiﬁcation of the downstream signaling pathw
with DTT or not for 4 hours (mock). (G) Assessment of XBP1 m
Evaluation of netrin-1, DAPK1, and PR65b depletion by immuno
is reversed by DAPK1 or PR65b knockdown. Graph indicates t
n ¼ 3; Mann–Whitney test; P < .05). (J) PP2A activity is increase
PR65b. Graph indicates PP2A activity ratio for each condition (
refer to statistical analyses.UNC5C pro-apoptotic pathway whereas UNC5A is known to
recruit NRAGE for apoptosis induction.62 However, UNC5B
is known to trigger apoptosis via PP2A-mediated dephos-
phorylation of DAPK1.16 In this study, silencing of PR65b,
the regulatory subunit of PP2A, was sufﬁcient to inhibit
UNC5A and UNC5C-mediated apoptosis, suggesting the
involvement of DAPK1. Because PP2A and DAPK1 have been
shown previously to be involved in UPR-induced
apoptosis,14 we investigated a possible link between
DAPK1 and the downstream signaling of UNC5A and UNC5C
during UPR-induced apoptosis. Our data suggest the
following: (1) netrin-1 could protect against UPR-induced
cell death by inhibiting pro-apoptotic pathways induced
by free UNC5A and UNC5C receptors, and (2) UNC5A and
UNC5C trigger apoptosis after recruitment of PP2A and
DAPK1 activation.
On a broader pathophysiological note, hepatocellular
carcinoma (HCC) constitutes a serious global medical chal-
lenge. Several chronic liver conditions leading to ﬁbrosis and
cirrhosis, which can in turn foster HCC onset, are associated
with ER stress.5,12 For instance, a1-antitrypsin deﬁciency is
sensitized to ER stress because of the misfolding of this
protein.63 Likewise, alcoholic liver disease and infection with
HBV or HCV are strong inducers of UPRs.7–9,30–32,64,65 Even
successfully treated HBV patients still experience a chronic
UPR because of the unchanged amount of secreted defective
subviral material that burdens the secretory pathway of the
affected hepatocytes.66 Activation of ER stress-induced
signaling is in turn instrumental for the development of
steatohepatitis and synergizes with proinﬂammatory path-
ways to promote hepatocarcinogenesis.67 It is believed that
cirrhosis imposes a high functional burden to the ER of the
remaining liver cells, in which increased production of
plasma proteins takes place to compensate for the loss of
hepatocytes as a result of liver damage. Hence, the UPR also
may promote cell survival during cirrhosis.7 The UPR is a
typical prerequisite for cancer development, namely in
highly secretory cell types. HCC is a strongly secretory tumor
type, which may in turn rely on this secretory addiction to
sustain transformation through the induction of the UPR.68
In this work, we have shown that the UPR makes cells
more dependent toward netrin-1 for survival, and netrin-1
may be angiogenic.69 The UPR contributes to tumor
growth and angiogenesis, enhancing the survival of cancerspase-3 activation through DAPK1/PR65b during UPR. (A)
n þ SEM, n ¼ 3). (B–F) Identiﬁcation of the implicated netrin-1
ed with DTT or not for 4 hours (mock). (B) Assessment of XBP1
sessment of netrin-1 protein knockdown by immunoblotting.
t knockdown efﬁciencies. Graphs indicate (D) UNC5A and (E)
with control siRNA-treated cells (mean þ SEM; n ¼ 3;
rsed by UNC5A or UNC5C knockdown after UPR induction.
s for each condition (mean þ SEM; n ¼ 3; Mann–Whitney test;
ay. HepaRG cells were transfected with siRNAs and treated
RNA splicing by RT-PCR. Representative result, n ¼ 3. (H)
blotting. Representative result, n ¼ 3. (I) Caspase-3 activation
he caspase-3 activity ratio for each condition (mean þ SEM;
d by netrin-1 depletion and reversed by reduced expression of
mean þ SEM; n ¼ 3; Mann–Whitney test; P < .05). *,**, or ***
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296 Lahlali et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 3cells to the hypoxic and low-nutrient conditions observed in
solid tumors such as HCC. Sorafenib, the approved targeted
therapy against HCC,70 fosters HCC cell death throughantiangiogenic activity71 and inhibition of the UPR.72–74
It is possible that, as is the case for any dynamic process
in biology, dual targeting of the UPR using sorafenib and
Figure 8. (See previous page). Tunicamycin activates UPR in mice. C57BL6 mice were treated with PBS or 1 mg/kg Tu and
killed 24 hours after treatment. (A) Pictures from livers harvested 24 hours after treatment. Representative result, n ¼ 7 (PBS),
n ¼ 8 (Tu). (B) Evaluation of netrin-1 protein overexpression by immunohistochemistry. Background level was assessed using
an isotype control antibody and pictures were taken at a magniﬁcation of 20. Representative result, n ¼ 7 (PBS), n ¼ 8 (Tu).
(C) Evaluation of eIF2a phosphorylation level at Ser-51 (P-eIF2a [Ser-51]) by immunoblotting (n ¼ 7 [PBS], n ¼ 8 [Tu]). (D–H).
Total RNA was extracted from mouse livers and GADD34, GRP94, total XBP1, CHOP, and p58IPK mRNA levels were quantiﬁed
by qRT-PCR (mean þ SEM; n ¼ 7 [PBS], n ¼ 8 [Tu]; Mann–Whitney test; P < .05). (I) Assessment of XBP1 mRNA splicing by
RT-PCR for each individual mouse. (*)PBS-treated mice showing weak, intrinsic, XBP1 mRNA splicing. *,**, or *** refer to
statistical analyses.
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Figure 9. Netrin-1 is
positively selected for
translation during UPR in
mice. C57BL6 mice were
treated with PBS or 1 mg/
kg Tu and killed 24 hours
after treatment. Livers
were snap-frozen, dis-
rupted in dry ice, and then
resuspended in polysome
lysis buffer. Lysates were
subjected to sucrose
gradient fractionation fol-
lowed by qRT-PCR to
quantify gus, b-actin,
netrin-1, c-myb, c-myc,
and ATF4 V1 mRNAs. (A)
Distribution of mRNAs
across sucrose gradients.
Bar graph represents RNA
fractions processed for b-
actin and netrin-1 mRNA
quantiﬁcation (mean þ
sem, n ¼ 5 [PBS], n ¼ 8
[Tu] for the entire ﬁgure).
Agarose gel electrophore-
ses reﬂects ribosomal
RNA distribution in the
gradient. (B) The evolution
of the association of indi-
cated mRNAs with poly-
somes was determined as
the percentage difference
of polysome-associated
mRNA signals in Tu sam-
ples vs mock samples
in each polysome proﬁle.
See also Supplementary
Figure 5.
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Figure 10. Netrin-1 reverts UPR-induced caspase-3 activation in netrin-1 transgenic mice. Netrin-1 (FLAG-tagged)
transgenic mice or control littermates were treated with Tamoxifen (Tamox), injected with PBS, or 1 mg/kg Tu and killed 24
hours after treatment. (A) Evaluation of netrin-1 protein overexpression by anti-FLAG immunoblotting. (B) Evaluation of netrin-1
protein overexpression by immunohistochemistry. Representative result, n ¼ 5 (wt/tamox/PBS), n ¼ 6 (wt/tamox/Tu), n ¼ 3
(netrin-1/tamox/PBS), n ¼ 5 (netrin-1/tamox/Tu for the whole ﬁgure). Background level was assessed using an isotype control
antibody. Magniﬁcation: 20. (C) Liver pictures 24 hours after treatment. (D) Evaluation of eIF2a phosphorylation by immu-
noblotting. (E) Caspase-3 activation after Tu treatment is reversed in netrin-1–expressing transgenic mice. Graph indicates fold
changes in caspase-3 activity compared with control mice (mean þ SEM; Mann–Whitney test; P < .05). (F) The number of
apoptotic cells is decreased in netrin-1 transgenic mice after Tu treatment. Graph indicates TUNEL positive cells/mm2 for each
group (mean þ SEM; Mann–Whitney test; P < .05). See also Supplementary Figure 6. *,**, or *** refer to statistical analyses.
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May 2016 Netrin–1 and the UPR in the Liver 299netrin-1 in HCC may decrease the dependency of HCC cells
toward netrin-1 for cell survival. Nevertheless, one can in
contrast hypothesize that potentially lower rates of secreted
netrin-1 as a result of sorafenib treatment may improve
netrin’s neutralization rates and therefore further affect
global survival of the tumor.
In summary, several chronic liver conditions, regardless
of being genetic, viral, or toxicologic in origin, feature
enhanced UPRs. Netrin-1 currently is targeted in phase 1
trials in nonhepatic oncology. Although dual UPR/netrin-
1–targeting approaches deserve preclinical investigations,
they may represent a hitherto unknown and innovative
option for addressing HCC onset and growth at the cirrhotic
level.
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Figure 1.Netrin-1 mRNA
level is not modulated
during UPR. HepaRG cells
were treated with (A) DTT
or (B) tunicamycin and sub-
jected to RT-qPCR for
quantiﬁcation of netrin-1
mRNA (Meanþ sem, n¼ 3).
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Figure 2. Differential as-
sociation of Netrin-1
5’UTR-related tran-
scripts with translational
units during UPR in
HepaRG cells. HepaRG
cells were treated with 2.5
mM DTT for 4 hours or left
untreated (Mock). Cell ly-
sates were subjected to
polysomes fractionation
followed by RT-qPCR for
quantiﬁcation of gus,
l-myc, c-myb, c-myc and
ATF4 V1 mRNAs. Bar
graphs depict Gus, l-myc,
c-myb, c-myc and ATF4
V1 mRNA quantiﬁcation
across fractions.
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Figure 3. Netrin-1 mRNA
association with trans-
lational units is un-
changed during UPR in
Huh7.5 cells. Huh7.5 cells
were treated with 2.5 mM
DTT for 4 hours of left un-
treated (Mock). Cell lysates
were subjected to sucrose
gradient fractionation fol-
lowed by RT-qPCR for
quantiﬁcation of b-actin,
netrin-1, l-myb, c-myb c-
myc and ATF4 V1 mRNA.
(A) Distribution of mRNAs
in the sucrose gradient.
Agarose gel electrophore-
ses show ribosomal RNA
distribution across sucrose
gradient. Bar graph repre-
sents RNA fractions pro-
cessed for b-actin and
netrin-1 mRNA quantiﬁca-
tion. (Mean þ sem). (B) The
evolution of the associa-
tion of indicated mRNAs
with polysomes was
determined as percentage
difference of polysome-
associated mRNA signals
in DTT samples vs mock
samples in each polysome
proﬁle.
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Figure 4. Differential as-
sociation of Netrin-1
5’UTR-related tran-
scripts with translational
units during UPR in
Huh7.5 cells. Huh7.5 cells
were treated with 2.5 mM
DTT for 4 hours of left un-
treated (Mock). Cell lysates
were subjected to sucrose
gradient fractionation fol-
lowed by RT-qPCR for
quantiﬁcation of l-myb,
c-myb c-myc and ATF4
mRNA. Figure shows dis-
tribution of mRNAs across
sucrose gradients.
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Figure 5. Differential as-
sociation of Netrin-1
related transcript with
translational units during
UPR in mice. C57BL6
mice were treated with
PBS or 1mg/kg Tunica-
mycin (Tu) and sacriﬁced
24 hours post-treatment.
Livers were snap-frozen,
disrupted in dry ice and
then resuspended in poly-
some lysis buffer. Lysates
were subjected to sucrose
gradient fractionation fol-
lowed by RT-qPCR to
quantify gus, c-myb c-myc
and ATF4 V1 mRNAs.
Figure shows distribution
of mRNAs across sucrose
gradients. Bar graph rep-
resents RNA fractions
processed for b-actin and
netrin-1 mRNA quantiﬁca-
tion ((Mean þ sem, n ¼ 5
(PBS), n ¼ 8 (Tu)). Agarose
gel electrophoreses reﬂects
ribosomal RNA distribution
in the sucrose gradient.
(Representative result, n þ
5 (PBS), nþ 8 (Tu)).
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Supplementary Figure 6. Monitoring of UPR activation in Netrin-1 transgenic mice. Netrin-1 transgenic mice or control
littermates treated with Tamoxifen (Tamox) were injected with PBS or 1mg/kg Tu and sacriﬁced 24 hours post-treatment. Total
RNA was extracted from mouse livers and subjected to RT-qPCR for quantiﬁcation of Netrin-1 overexpression (A), GADD34
(B), total XBP1 (C), GRP94 (D), CHOP (E) and p58IPK (F) mRNAs. (Mean þ sem, n ¼ 5 (wt/tamox/PBS), n ¼ 6 (wt/tamox/Tu),
n ¼ 3 (netrin-1/tamox/PBS), n ¼ 5 (netrin-1/tamox/Tu), Mann-Whitney test, P<.05). (G) Assessment of XBP1 mRNA splicing by
RT-PCR in each individual.
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Supplementary Table 1.Human Primers
Gene name
Genbank
accession number Primer sequences PCR conditions
Amplicon
length, bp
Netrin-1 NM_004822 Forward: CTTCTGCGGCAGGCGGACAGAT;
reverse: ACGCGTTGCAGAGGTGGCACGA
Denaturation, 95C;
annealing, 65C
(qPCR with 10% DMSO)
385
Gus NM_001293105 Forward: CGTGGTTGGAGAGCTCATTTGGAA;
reverse: TTCCCCAGCACTCTCGTCGGT
Denaturation, 95C;
annealing, 60C
72
b-actin XM_006715764.1 Forward: CACCATTGGCAATGAGCGGTTC;
reverse: AGGTCTTTGCGGATGTCCACGT
Denaturation, 95C;
annealing, 60C
135
p58IPK NM_006260.4 Forward: CGTTCACAAGCACTTAACGCT;
reverse: GTTCTGCATCCCAAACACAAAC
Denaturation, 95C;
annealing, 55C
97
GADD34 NM_014330.3 Forward: ATGATGGCATGTATGGTGAGC;
reverse: AACCTTGCAGTGTCCTTATCAG
Denaturation, 95C;
annealing, 55C
120
GRP94 NM_003299.2 Forward: CCCCATGGCTTATATTCACTTTAC;
reverse: TCTTGTTTTTCCTTCATTCTTTCC
Denaturation, 95C;
annealing, 60C
504
CHOP NM_004083.5 Forward: AAGGCACTGAGCGTATCATGT;
reverse: TGAAGATACACTTCCTTCTTGAAC
Denaturation, 95C;
annealing, 60C
105
Total Xbp1 NM_005080.3 Forward: CCCTCCAGAACATCTCCCCAT;
reverse: ACATGACTGGGTCCAAGTTGT
Denaturation, 95C;
annealing, 55C
101
Xbp1 NM_005080.3
NM_001079539.1
Forward: GGAACAGCAAGTGGTAGA;
reverse: CTGGAGGGGTGACAAC
Denaturation, 95C;
annealing, 60C
259/233
l-myc NM_001033081.2 Forward: CCATCAGCAACAGCACAACTA;
reverse CACTTTCTACAGGTGGGGGA
Denaturation, 95C;
annealing, 55C
167
c-myb XM_006715495.1 Forward: GAAAGCGTCACTTGGGGAAAA;
reverse: TGTTCGATTCGGGAGATAATTGG
Denaturation, 95C;
annealing, 55C
122
c-myc NM_002467.4 Forward: ACCACCAGCAGCGACTCTGA;
reverse: TGCCAGGAGCCTGCCTCTTT
Denaturation, 95C;
annealing, 55C
85
ATF4 V1 NM_001675.4 Forward: CCACCATGGCGTATTAGGGG;
reverse: GCACCCCACCAATCCAAAAC
Denaturation, 95C;
annealing, 55C
177
DAPK1 NM_001288731.1 Forward: ACGTGGATGATTACTACGACACC;
reverse: TGCTTTTCTCACGGCATTTCT
Denaturation, 95C;
annealing, 57C
81
PR65b NM_001161660.1 Forward: CTTGGCGCGTTCGCTATATG;
reverse: GGCGGGGATGAGGTCATTTAG
Denaturation, 95C;
annealing, 57C
92
UNC5A XM_006714928.1 Forward: CATCACCAAGGACACAAGGTTTGC;
reverse: GGCTGGAAATTATCTTCTGCCGAA
Denaturation, 95C;
annealing, 57C
125
UNC5B NM_170744.4
NM_001244889.1
Forward: GGGCTGGAGGATTACTGG;
reverse: TGCAGGAGAACCTCATGGTC
Denaturation, 95C;
annealing, 60C
155
UNC5C NM_003728.3 Forward: GCAAATTGCTGGCTAAATATCAGGAA;
reverse: GCTCCACTGTGTTCAGGCTAAATCTT
Denaturation, 95C;
annealing, 60C
114
UNC5D NM_080872.2 Forward: GGTGAACCCAGCCTCCAGTCAG;
Reverse: CTTCCACTGACATCACTTCCTCCC
Denaturation, 95C;
annealing, 60C
199
DCC XM_005258204.1 Forward: AGCCAATGGGAAAATTACTGCTTAC;
reverse: AGGTTGAGATCCATGATTTGATGAG
Denaturation, 95C;
annealing, 60C
126
DMSO, dimethyl sulfoxide.
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Supplementary Table 2.Mouse Primers
Gene name
Genbank
accession number Primer sequences PCR conditions
Amplicon
length, bp
Mouse b-actin NM_007393.3 Forward: GCAGGAGTACGATGAGTCCG;
reverse: ACGCAGCTCAGTAACAGTCC
Denaturation, 95C;
annealing, 55C
74
Mouse Gus NM_010368.1 Forward: GTGGTATGAACGGGAAGCAAT;
reverse: AACTGCATAATAATGGGCACTGT
Denaturation, 95C;
annealing, 55C
97
Mouse netrin-1 NM_008744.2 Forward: CCTGTCACCTCTGCAACTCT;
reverse: TGTGCGGGTTATTGAGGTCG
Denaturation, 95C;
annealing, 55C
78
Mouse GADD34 NM_008654.2 Forward: CCCAGCGTTGTCTACCAGG;
reverse: CGGGTAAATAGAAGGCCACCT
Denaturation, 95C;
annealing, 55C
81
Mouse GRP94 NM_011631.1 Forward: GTTCGTCAGAGCTGATGATGAA;
reverse: GCGTTTAACCCATCCAACTGAAT
Denaturation, 95C;
annealing, 55C
138
Mouse CHOP NM_007837.4 Forward: AAGCCTGGTATGAGGATCTGC;
reverse: TTCCTGGGGATGAGATATAGGTG
Denaturation, 95C;
annealing, 55C
75
Mouse P58IPK NM_008929.3 Forward: CACCAAAGTGATTGCGCTGAA;
reverse: ATCGTCTTCTGCTTCGTCAAG
Denaturation, 95C;
annealing, 55C
100
Mouse total Xbp1 NM_001271730.1 Forward: AGCTTTTACGGGAGAAAACTCAC;
reverse: CCTCTGGAACCTCGTCAGGA
Denaturation, 95C;
annealing, 55C
99
Mouse Xbp1 NM_001271730.1
NM_013842.3
Forward: AGCAGCAAGTGGTGGA;
reverse: CTGGGGAGGTGACAAC
Denaturation, 95C;
annealing, 60C
263/237
Mouse c-myb NM_001198914.1 Forward: GAAAGCGTCACTTGGGGAAAA;
reverse: TGTCCGGTTGGGCAGATAATTGG
Denaturation, 95C;
annealing, 55C
122
Mouse c-myc NM_001177353.1 Forward: ACCACCAGCAGCGACTCTGA;
reverse: TGGCAGGGGTTTGCCTCTTC
Denaturation, 95C;
annealing, 55C
85
Mouse ATF4 V1 NM_009716.3 Forward: CCGGAAATTCGTCAACGAGC;
reverse: AGATCGTCCTAAAGGCCCCA
Denaturation, 95C;
annealing, 54C
109
Supplementary Table 3.Other Primers
Gene name
Genbank
accession number Primer sequences PCR conditions
Amplicon
length, bp
Netrin-1 (5’UTR
1-294)
NM_004822 Forward: (T7p5’UTR_Netrin-1)
TAATACGACTCACTATAGCTTCGGGGGCGAGC;
reverse: (cas-as5’UTR_Netrin-1)
GAACCGGACCGAAGCCCGATTTGGATCCGGCG
AACCGGATCGACCTTGCCGAAGGCCGCAT
Denaturation, 95C;
annealing, 65C
(qPCR with 10% DMSO)
294
/ / Forward: (primer Std) GAACCGGACCGAAGCCCG / /
Fluc / Forward: TGTCCACCTCGATATGTGCATC / /
/ signify that there is no gene name, PCR conditions and amplicon length for these primers. They were used as labeled probes.
DMSO, dimethyl sulfoxide.
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Supplementary Table 4.siRNA Sequences
Target
gene siRNA sequence 5’-3’ Source
Control Commercial SIC001 (Sigma)
Netrin-1 AAGCUGGACGCAGCAUGAUGC Sigma
UNC5A CUGGACACCCGCAACUGUA Sigma
UNC5C CUCUAUGUUGGGAUUGUGA Sigma
DAPK1 Commercial EHU015411 (Sigma)
PR65b Commercial EHU059311 (Sigma)
Supplementary Table 5.Antibody Information
Target protein Name References
HA-Tag Monoclonal anti-HA antibody H3663 (Sigma)
FLAG-M2 Monoclonal anti-FLAG M2 antibody F3165 (Sigma)
Netrin-1 Polyclonal anti–netrin-1 antibody AF1109 (R&D Systems)
Netrin-1 Polyclonal anti–netrin-1 antibody MAB1109 (R&D Systems)
b-actin Polyclonal anti–b-actin antibody A1978 (Sigma)
DAPK1 Monoclonal anti-DAPK1 antibody D2178 (Sigma)
PR65b Monoclonal anti-PP2R1B antibody Ab154815 (Abcam)
eIF2a Polyclonal anti-eIF2a antibody 9722 (Cell Signaling)
Phospho-eIF2a (Ser-51) Polyclonal anti–phospho-eIF2a (Ser51) antibody 9721 (Cell Signaling)
a-tubulin Polyclonal anti–a-tubulin antibody PA1-20988 (Thermo Scientiﬁc)
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